Feasibility of Enhanced Recovery After Surgery Without Prophylactic Abdominal Drainage Tubes After Laparoscopic Distal Gastrectomy For Gastric Cancer: A Prospective, Multicenter, Non-inferiority, Randomized, Open-label, Controlled Trial

Status: Recruiting
Location: See all (6) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

This study aims to compare the effects of using prophylactic abdominal drainage tubes during Enhanced Recovery After Surgery (ERAS) in patients undergoing Laparoscopic Distal Gastrectomy (LDG) for gastric cancer through a multicenter non-inferiority randomized trial. The study is divided into two groups: 1. ERAS-tubeless group: The ERAS protocol without nasogastric decompression, nasojejunal feeding or prophylactic abdominal drainage tubes. 2. ERAS-tube group: the ERAS protocol with prophylactic abdominal drainage tubes, along with no nasogastric decompression or nasojejunal feeding tubes. Patients will be randomly assigned to the two groups in a 1:1 ratio, with the primary analysis based on the modified intention-to-treat population (mITT) and secondary analysis on the per-protocol (PP) population. Perioperative management will adhere to ERAS guidelines, and postoperative quality of life will be assessed using the EORTC QLQ-C30 questionnaire and QoR-15 scores. Preliminary training on the standard ERAS protocol is administered to all members in the team before the initiation of the study, ensuring in-group members to fully master the requirements and other related contents in the study. Data collectors, analysts, and outcome evaluators will remain blinded to group allocation. The findings of this study are expected to provide high-quality evidence on the feasibility of omitting prophylactic abdominal drainage in the context of ERAS, thereby contributing to the optimization of postoperative management strategies for gastric cancer surgery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Patients' age from 18 to 80 years old;

• Histopathologically confirmed gastric adenocarcinoma;

• Clinical tumor stage of cT1-4N0-3M0;

• Laparoscopic distal gastrectomy approach;

• ECOG score of 0-1;

• Written informed consent

Locations
Other Locations
China
International Hospital of Pecking University
RECRUITING
Beijing
Fujian Medical University Union Hospital
RECRUITING
Fuzhou
Lanzhou University Second Hospital
RECRUITING
Lanzhou
Sun Yat-sen University Cancer Center Gansu Hospital
RECRUITING
Lanzhou
The First Affiliated Hospital of Xi'an Jiaotong University
RECRUITING
Xi'an
Zhejiang Cancer Hospital
RECRUITING
Zhejiang
Contact Information
Primary
Zuoyi Jiao, M.D.
jiaozy@lzu.edu.cn
+86-0931-5190920
Time Frame
Start Date: 2025-06-16
Estimated Completion Date: 2028-09-10
Participants
Target number of participants: 454
Treatments
Experimental: ERAS-tubeless group
Nasogastric decompression tube is not placed preoperatively; If necessary, nasogastric decompression tube is placed after anesthesia induction during surgery and removed when the reconstruction is performed; No abdominal drainage and nasojejunal feeding tubes were placed intraoperatively; None of these 3 tubes were present postoperatively.
Active_comparator: ERAS-tube group
Nasogastric decompression tube is not placed preoperatively; If necessary, nasogastric decompression tube is placed after anesthesia induction during surgery and removed when the reconstruction is performed; Nasojejunal feeding tube is not placed intraoperatively; 1 prophylactic abdominal drainage tube is placed at the duodenal stump for LDG and retained postoperatively.
Related Therapeutic Areas
Sponsors
Leads: Zuoyi Jiao

This content was sourced from clinicaltrials.gov